BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20616080)

  • 1. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells.
    Alipio Z; Liao W; Roemer EJ; Waner M; Fink LM; Ward DC; Ma Y
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13426-31. PubMed ID: 20616080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
    Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
    Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic β cells.
    Manzar GS; Kim EM; Zavazava N
    J Biol Chem; 2017 Aug; 292(34):14066-14079. PubMed ID: 28360105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
    Bose B; Katikireddy KR; Shenoy PS
    Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of iPSCs into insulin-producing cells via adenoviral transfection of PDX-1, NeuroD1 and MafA.
    Wang L; Huang Y; Guo Q; Fan X; Lu Y; Zhu S; Wang Y; Bo X; Chang X; Zhu M; Wang Z
    Diabetes Res Clin Pract; 2014 Jun; 104(3):383-92. PubMed ID: 24794627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of hyperglycemia by insulin-secreting rat bone marrow- and blastocyst-derived hypoblast stem cell-like cells.
    Kumar A; Lo Nigro A; Gysemans C; Cai Q; Esguerra C; Nelson-Holte M; Heremans Y; Jiménez-González M; Porciuncula A; Mathieu C; Binas B; Heimberg H; Prosper F; Hering B; Verfaillie CM; Barajas M
    PLoS One; 2013; 8(5):e63491. PubMed ID: 23671681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human insulin secreted from insulinogenic xenograft restores normoglycemia in type 1 diabetic mice without immunosuppression.
    Kim J; Park S; Kang HM; Ahn CW; Kwon HC; Song JH; Lee YJ; Lee KH; Yang H; Baek SY; Yoo SH; Kim SH; Kim H
    Cell Transplant; 2012; 21(10):2131-47. PubMed ID: 22490341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
    Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
    J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of hyperglycemia in type 1 diabetic models by transplantation of encapsulated insulin-producing cells derived from mouse embryo progenitor.
    Shao S; Gao Y; Xie B; Xie F; Lim SK; Li G
    J Endocrinol; 2011 Mar; 208(3):245-55. PubMed ID: 21212095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice.
    Kang HM; Kim J; Park S; Kim J; Kim H; Kim KS; Lee EJ; Seo SI; Kang SG; Lee JE; Lim H
    Stem Cells; 2009 Aug; 27(8):1999-2008. PubMed ID: 19544420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice.
    Vegas AJ; Veiseh O; Gürtler M; Millman JR; Pagliuca FW; Bader AR; Doloff JC; Li J; Chen M; Olejnik K; Tam HH; Jhunjhunwala S; Langan E; Aresta-Dasilva S; Gandham S; McGarrigle JJ; Bochenek MA; Hollister-Lock J; Oberholzer J; Greiner DL; Weir GC; Melton DA; Langer R; Anderson DG
    Nat Med; 2016 Mar; 22(3):306-11. PubMed ID: 26808346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells.
    Zhu FF; Zhang PB; Zhang DH; Sui X; Yin M; Xiang TT; Shi Y; Ding MX; Deng H
    Diabetologia; 2011 Sep; 54(9):2325-36. PubMed ID: 21755313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGF Facilitates Direct Lineage Reprogramming of Hepatocytes to Functional β-Like Cells Induced by Pdx1 and Ngn3.
    Chang FP; Cho CH; Shen CR; Chien CY; Ting LW; Lee HS; Shen CN
    Cell Transplant; 2016 Oct; 25(10):1893-1909. PubMed ID: 27076404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroencapsulated Human iPSC-Derived Pancreatic Progenitors Protect against STZ-Induced Hyperglycemia in Mice.
    Haller C; Piccand J; De Franceschi F; Ohi Y; Bhoumik A; Boss C; De Marchi U; Jacot G; Metairon S; Descombes P; Wiederkehr A; Palini A; Bouche N; Steiner P; Kelly OG; R-C Kraus M
    Stem Cell Reports; 2019 Apr; 12(4):787-800. PubMed ID: 30853374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of glucose-responsive functional islets with a three-dimensional structure from mouse fetal pancreatic cells and iPS cells in vitro.
    Saito H; Takeuchi M; Chida K; Miyajima A
    PLoS One; 2011; 6(12):e28209. PubMed ID: 22145030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Diabetes Mellitus Using iPS Cells and Spice Polyphenols.
    Ge Q; Chen L; Chen K
    J Diabetes Res; 2017; 2017():5837804. PubMed ID: 28758131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generating insulin-producing cells for diabetic therapy: existing strategies and new development.
    Shen J; Cheng Y; Han Q; Mu Y; Han W
    Ageing Res Rev; 2013 Mar; 12(2):469-78. PubMed ID: 23318683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of Tonsil-Derived Mesenchymal Stem Cells Improves Glucose Tolerance in High Fat Diet-Induced Diabetic Mice via Insulin-Like Growth Factor-Binding Protein 5-Mediated Endoplasmic Reticulum Stress Modulation.
    Lee Y; Shin SH; Cho KA; Kim YH; Woo SY; Kim HS; Jung SC; Jo I; Jun HS; Park WJ; Park JW; Ryu KH
    Cells; 2019 Apr; 8(4):. PubMed ID: 31018536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of human pluripotent stem cell-derived pancreatic β-like cells in the mouse pancreas.
    Ma H; Wert KJ; Shvartsman D; Melton DA; Jaenisch R
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3924-3929. PubMed ID: 29599125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.